Plants make specialized bioactive metabolites to defend themselves against attackers. The conserved control mechanisms are based on transcriptional activation of the respective plant speciesspecific biosynthetic pathways by the phytohormone jasmonate. Knowledge of the transcription factors involved, particularly in terpenoid biosynthesis, remains fragmentary. By transcriptome analysis and functional screens in the medicinal plant Catharanthus roseus (Madagascar periwinkle), the unique source of the monoterpenoid indole alkaloid (MIA)-type anticancer drugs vincristine and vinblastine, we identified a jasmonate-regulated basic helix-loop-helix (bHLH) transcription factor from clade IVa inducing the monoterpenoid branch of the MIA pathway. The bHLH iridoid synthesis 1 (BIS1) transcription factor transactivated the expression of all of the genes encoding the enzymes that catalyze the sequential conversion of the ubiquitous terpenoid precursor geranyl diphosphate to the iridoid loganic acid. BIS1 acted in a complementary manner to the previously characterized ethylene response factor Octadecanoid derivative-Responsive Catharanthus APETALA2-domain 3 (ORCA3) that transactivates the expression of several genes encoding the enzymes catalyzing the conversion of loganic acid to the downstream MIAs. In contrast to ORCA3, overexpression of BIS1 was sufficient to boost production of highvalue iridoids and MIAs in C. roseus suspension cell cultures. Hence, BIS1 might be a metabolic engineering tool to produce sustainably high-value MIAs in C. roseus plants or cultures.
Plants make specialized bioactive metabolites to defend themselves against attackers. The conserved control mechanisms are based on transcriptional activation of the respective plant speciesspecific biosynthetic pathways by the phytohormone jasmonate. Knowledge of the transcription factors involved, particularly in terpenoid biosynthesis, remains fragmentary. By transcriptome analysis and functional screens in the medicinal plant Catharanthus roseus (Madagascar periwinkle), the unique source of the monoterpenoid indole alkaloid (MIA)-type anticancer drugs vincristine and vinblastine, we identified a jasmonate-regulated basic helix-loop-helix (bHLH) transcription factor from clade IVa inducing the monoterpenoid branch of the MIA pathway. The bHLH iridoid synthesis 1 (BIS1) transcription factor transactivated the expression of all of the genes encoding the enzymes that catalyze the sequential conversion of the ubiquitous terpenoid precursor geranyl diphosphate to the iridoid loganic acid. BIS1 acted in a complementary manner to the previously characterized ethylene response factor Octadecanoid derivative-Responsive Catharanthus APETALA2-domain 3 (ORCA3) that transactivates the expression of several genes encoding the enzymes catalyzing the conversion of loganic acid to the downstream MIAs. In contrast to ORCA3, overexpression of BIS1 was sufficient to boost production of highvalue iridoids and MIAs in C. roseus suspension cell cultures. Hence, BIS1 might be a metabolic engineering tool to produce sustainably high-value MIAs in C. roseus plants or cultures.
basic helix loop helix | Catharanthus roseus | jasmonate | Madagascar periwinkle | iridoids P lants produce a vast amount of natural products, also called specialized metabolites, by which they can interact with their environment to ensure survival and reproductive success. These compounds often have bioactive properties that make them valuable for various pharmaceutical applications. The phytohormone jasmonate (JA) acts as an elicitor of the production of these bioactive metabolites and triggers a transcriptional reprogramming of plant metabolism, resulting in a concerted upregulation of the expression of genes encoding enzymes involved in specific specialized metabolic pathways (1) . The specialized defense metabolites are generally produced from primary metabolites, leading to precursor competition with cellular processes implicated in growth and development. For instance, terpenoid biosynthesis depends on the precursor isopentenyl diphosphate (IPP), which is produced either via the plastidial 2-C-methyl-D-erythritol 4-phosphate (MEP) or the cytosolic mevalonate (MVA) pathways (Fig. 1A) . In the medicinal plant Catharanthus roseus (Madagascar periwinkle), the MEP pathway-derived IPP is one of the precursors of the monoterpenoid indole alkaloid (MIA) pathway that leads to the valuable anticancer molecules vincristine and vinblastine, of which C. roseus is the sole source (2-4), whereas the MVA-derived IPP is the precursor of the pentacyclic triterpenoid pathway (5, 6) (Fig.  1A) . As IPP is also the precursor for the synthesis of gibberellins, brassinosteroids, phytosterols, carotenoids, and phytol, among others, the tight regulation of both IPP supply and consumption is crucial.
In C. roseus, the MEP-derived production of the monoterpenoid, more specifically seco-iridoid, compound secologanin involves 10 enzymatic conversions starting from IPP, of which the eight genes upstream of loganic acid methyltransferase (LAMT) are tightly coexpressed ( Fig. 1) (2, 3, 7) . Secologanin is subsequently coupled to the indole compound tryptamine, forming the common alkaloid precursor strictosidine, from which all MIAs are derived (Fig. 1A) . In contrast to the triterpenoid genes in C. roseus, genes involved in MIA production are JA inducible, clearly pointing to distinct regulatory circuits governing these two terpenoid pathways ( Fig. 1) (8) .
The concerted regulation of JA-induced genes is mediated by transcription factors (TFs) that are usually encoded by JA-inducible genes themselves (1) . A combinatorial role for several TFs seems a plausible strategy for the control of biosynthetic
Significance
Terpenoids are the largest group of plant-specialized metabolites and include many valuable bioactive compounds, such as the blockbuster anticancer drugs vincristine and vinblastine, that are monoterpenoid indole alkaloids from the medicinal plant Catharanthus roseus (Madagascar periwinkle). A master regulator was discovered that activates the biosynthesis of the iridoids, the monoterpenoid precursors of vinblastine and vincristine, and the rate-limiting branch in their biosynthetic pathway. This master regulator can be used to boost production of iridoids and monoterpenoid indole alkaloids in C. roseus cell cultures and thus represents an interesting tool for the metabolic engineering of the sustainable production of these high-value compounds in cultures of the endogenous plant species.
pathways by JAs, but the identity of such TF arrays has so far remained elusive for most terpenoid pathways (1) . The basic helix-loop-helix (bHLH) TF MYC2 has emerged as a central regulator in JA signaling cascades, including those leading to the biosynthesis of several classes of specialized metabolites (9) . MYC2-type TFs have been shown to be involved in the regulation of terpene biosynthesis genes in Arabidopsis thaliana, Artemisia annua (sweet wormwood), and Solanum lycopersicum (tomato) (10) (11) (12) . In C. roseus, MYC2 regulates the expression of the ethylene response factor (ERF) Octadecanoid derivativeResponsive Catharanthus APETALA2-domain 3 (ORCA3) (13), the JA-inducible regulatory TF that modulates the JA-induced expression of the genes of the indole branch of the pathway, strictosidine synthase (STR), and several steps downstream of strictosidine, thereby controlling part of the JA-responsive production of MIAs (14, 15) . However, the iridoid genes upstream of LAMT, such as geraniol-8-oxidase (G8O), are not under the control of ORCA3 (Fig. 1) (14) but are clearly responsive to JA, as illustrated by transcriptome (8, 14) and G8O promoter (16) analysis, suggesting that several regulatory circuits might exist that drive divergent gene expression in the MIA pathway. These circuits probably involve both repressors and activators, such as the previously studied C. roseus G-box binding factors (GBFs), WRKY1, AT-hook, and zinc finger TFs (17) (18) (19) (20) , or TFs that interact with MYC2, for instance, as reported in Arabidopsis (21, 22).
As the accumulation of MIAs is low, leading to scarcity and high market prices, there is a general interest to boost the production of these compounds in planta. The use of TFs can be a powerful tool in such metabolic engineering programs. ORCA3 has been overexpressed in cell suspensions, hairy roots, and plants in attempts to increase MIA production (14, (23) (24) (25) . However, because ORCA3 does not activate iridoid genes, MIA accumulation in these lines required either coexpression with G8O or feeding with iridoid precursors. Given the rate-limiting nature of the iridoid pathway in C. roseus cultures, we launched a screen, based on transcriptome analysis, to discover iridoidregulating TFs.
Results
Identification of a pG8O-Transactivating TF. To identify regulators of the iridoid pathway branch, we set up a screen for transactivators of the G8O promoter (pG8O), the sequence of which had been determined previously (16) . Candidate TFs were selected by mining recently generated RNA-Seq data (7, 8, 26) for TFs that showed coexpression with the iridoid genes upstream of LAMT. Essentially, TF encoding genes that showed expression patterns similar to G8O in the RNA-Seq data generated by the SmartCell consortium (bioinformatics.psb.ugent.be/orcae/ overview/Catro), i.e., JA induced in both cell suspensions and seedlings but not induced by ORCA overexpression in cell suspensions, were selected for further analysis. Among them, AO  MAT  SQS  SQE1  NMT  DXS1  PMK  AAS  HMGR1  STR2  HMGS  ORCA3  D4H  T19H  STR1  SLS2  SLS1  PRX1  TDC  DXS2A  T16OMT  DXS2A  DXR  G8O  GES  HMGR2  8HGO  T16H1  IS  BIS1  GPPS-SSU  MVD  SGD  IO  CMK  MYC2  HDR  CMS  MECS  7DLH  7DLGT  HDS  LAMT  DAT  T16H2  MVK  AACT1   LAMT  SLS2  TDC  SLS1  STR1  HMGR2  MYC2  ORCA3  MVK  GPPS-SSU  MVD  T16OMT  T19H  MAT  SGD  AACT1  PMK  7DLH  7DLGT  DXS2B  HMGR1  G8O  GES  IS  IO  BIS1  DXS2A  8HGO  DXR  CMK  HDS  HDR  HMGS  CMS  SQS  AO  DXS1  D4H  DAT  AAS  T16H2  SQE1  MECS  PRX1  T16H1 a bHLH TF belonging to clade IVa of the family (27) ( Fig. 1 B and C and SI Appendix, Fig. S1 ) was capable of transactivating pG8O 95.3-fold in a Nicotiana tabacum (tobacco) protoplastbased screen ( Fig. 2A) . The gene encoding this bHLH TF, designated "bHLH Iridoid Synthesis 1" (BIS1; Caros001862), responded to JA similarly to the genes encoding the enzymes involved in the iridoid and MIA pathways and those encoding known regulators, such as ORCA3 and MYC2 (Fig. 1C) . Contrary to BIS1, the latter two transactivated pG8O only by 1.7-fold and 1.1-fold, respectively ( Fig. 2A) . Leaf disk assays with agroinfiltrated Nicotiana benthamiana plants confirmed the effect of BIS1 on pG8O (Fig. 2B) . Finally, these results were corroborated by transient transactivation assays in bombarded C. roseus cells (Fig. 2C ).
BIS1 Specifically Transactivates the Iridoid Pathway Branch Upstream
of LAMT. Iridoid genes upstream of LAMT in C. roseus are highly coexpressed with G8O and thus might potentially be under a similar regulatory control. To test this hypothesis, we isolated the gene promoters of geraniol synthase (GES), 8-hydroxygeraniol oxidase (8HGO), iridoid synthase (IS), iridoid oxidase (IO), 7-deoxyloganetic acid glucosyltransferase (7DLGT), 7-deoxyloganic acid hydroxylase (7DLH), and LAMT from the recently revealed C. roseus genome sequence (28) , as well as of the ORCA3-dependent gene STR1, and assessed them for transactivation by BIS1, MYC2, and ORCA3 (Fig. 2) . In tobacco protoplasts, BIS1 was able to induce all iridoid promoters 31-to 95-fold, except for pIO ( Fig. 2A) . In contrast, ORCA3 only marginally transactivated the iridoid promoters, usually by less than twofold, except for pIS, which was induced 4.9-fold ( Fig. 2A) . No significant transactivation with MYC2 was observed for any of the iridoid promoters. As the minor effect of ORCA3 on these promoters did not correlate with increased expression of the corresponding genes in the ORCA3-overexpressing cell line (as determined by RNA-Seq analysis; Fig. 1C and SI Appendix, Table S2 ) (7), we did not further consider it. Conversely, the promoter of the known ORCA3 target gene STR1 was induced 24.7-fold by ORCA3 and only 1.3-fold by either BIS1 or MYC2 in tobacco protoplasts ( Fig. 2A) . The effect of ORCA3 on pSTR1 was validated in the N. benthamiana leaf assay, in which BIS1 or MYC2 slightly repressed the pSTR1-driven reporter expression (Fig. 2B) . The LAMT promoter derivative used here could not be transactivated by any TF (Fig. 2B) . Hence, the action range of BIS1 is limited to the iridoid branch of the MIA pathway (up to loganic acid synthesis) and is clearly distinct from that of ORCA3.
BIS1 Boosts MIA Production in C. roseus Cell Cultures. In contrast to differentiated C. roseus plant tissues, the C. roseus cell suspension line MP183L accumulates only trace amounts of secologanin, strictosidine, or MIAs without exogenous supply of JA or loganin.
In addition and in contrast to the ORCA3-dependent genes, G8O transcripts could not be detected in wild-type cells, illustrating the limiting nature of the seco-iridoid pathway in this cell line (14) . The RNA-Seq data analysis confirmed the low transcript accumulation of all MEP and iridoid genes in nonelicited cells compared with that of the ORCA3-regulated genes, such as LAMT, SLS1, and STR1 (SI Appendix, Table S2 ). Overexpression of ORCA3 in this cell line increased the expression of LAMT, STR, and SLS, among other genes, but not of the iridoid genes upstream of LAMT (Fig. 1C) (7, 14) . Accordingly, an increase in MIA accumulation in the ORCA3-overexpressing cells could only be achieved after addition of loganin to the cell culture medium (14) .
To evaluate the effect of BIS1 on MIA production and assess its value as a metabolic engineering tool, we generated three stable transgenic MP183L suspension cell lines constitutively overexpressing BIS1 (Fig. 3) . Compared with control lines expressing the gene encoding the green fluorescent protein (GFP), BIS1 overexpression resulted in a high up-regulation of MEP genes and the iridoid genes upstream of LAMT in three independent BIS1 lines, whereas transcript accumulation of ORCA3-dependent genes remained unaltered (Fig. 3A) . This up-regulation was accompanied by a strong effect on the metabolite level (Fig. 3B) . In contrast to . In all cases, statistical significance was determined by the Student's t test (*P < 0.05, **P < 0.005, ***P < 0.0005). wild-type and control cells, the (seco)-iridoids loganic acid and secologanin accumulated in the BIS1-overexpressing cells. Likewise, we observed a strong accumulation of strictosidine, indicating that the tryptamine levels were not limiting, as well as of the downstream MIA compounds ajmalicine, serpentine, and tabersonine to levels previously unreported in untreated MP183L cells. In control cell lines, none of these MIA compounds accumulated to detectable levels. Together these data demonstrate that BIS1 overexpression is sufficient to boost MIA production in C. roseus MP183L cells.
BIS1 Specifically Up-Regulates the Iridoid Genes in C. roseus Hairy
Roots. Overexpression of G8O had previously been reported to be sufficient to increase MIA accumulation in C. roseus hairy roots (24) . Therefore, we also generated C. roseus hairy roots that overexpressed BIS1. In contrast to the cell suspensions, MIA accumulation did not increase in the transgenic hairy root lines (Fig. 4A) , despite clear BIS1 overexpression (Fig. 4B) . Previously, MIA metabolite levels had not been found to increase significantly in ORCA3-overexpressing C. roseus hairy root lines either, not even after loganin and tryptophan feeding (23) . This observation correlated not only with the anticipated lack of G8O induction but, unexpectedly, also with unaltered tryptophan decarboxylase (TDC) and repressed strictosidine-β-glucosidase (SGD) expression (23), two ORCA3-inducible genes in cell cultures (14) .
To assess whether analogous flux limitations would occur in the BIS1-overexpressing roots, we carried out a transcriptome analysis by RNA-Seq. As in suspension cells, BIS1 overexpression up-regulated the expression of all iridoid genes upstream of LAMT (Fig. 4D) but not of the ORCA3 target gene STR1 (Fig. 4C) . Overexpression of BIS1 also resulted in increased transcript accumulation of the genes encoding all MEP pathway enzymes and the geranyl diphosphate (GPP) synthase small subunit (Fig. 4E and SI Appendix, Table S2 ) but in a decreased expression of the ORCA3 target genes LAMT, secologanin synthase (SLS), TDC, and SGD (Fig. 4C and SI Appendix, Table S2 ). The latter effect might create a flux limit and might explain that BIS1 overexpression does not lead to increased MIA accumulation in hairy roots. Decreased expression of the ORCA3 target genes was not caused by decreased expression of ORCA2 or ORCA3, nor of any other known C. roseus TF encoding gene previously linked with regulation of the MIA pathway (SI Appendix, Fig. S2 ), and thus involves other, yet unknown, regulatory mechanisms.
It is conceivable that the increased MEP pathway activity may involve widespread reprogramming of terpenoid pathways dependent on MEP-derived IPP and GPP. To assess this, we mined the RNA-Seq data for genes encoding enzymes involved in MEP-dependent terpene biosynthesis, encompassing the monoterpenoid, diterpenoid (gibberellins), and carotenoid and phytyldiphosphate-reliant (chlorophyll and tocopherol) biosynthetic pathways. This analysis indicated that none of the above pathways was affected by BIS1 overexpression in hairy roots (SI Appendix, Fig. S3 ). In concordance with this observation, expression of the genes involved in these pathways was not affected by JA elicitation either (SI Appendix, Fig. S3 ).
C. roseus also produces pentacyclic triterpenoids, such as ursolate and oleanolate (5, 6) , that are synthesized from MVA pathway-derived IPP. As BIS1 is JA inducible but the C. roseus triterpenoid pathway genes are not (8), we anticipated that the triterpenoid pathway genes would not be affected by BIS1 overexpression, as was indeed the case (Fig. 4E) . Moreover, the triterpenoid precursor MVA pathway genes were not induced by BIS1 overexpression or by JA treatment (Fig. 4E) either, the latter in contrast to many other plant species (29) . Together, this transcriptome analysis delineates the BIS1 specificity as a transcriptional activator of the iridoid pathway up to loganic acid.
Silencing of BIS1 Reduces MIA Accumulation in Planta. Finally, we carried out a loss-of-function analysis of BIS1 in two different systems. First, virus-induced silencing (VIGS) was used to silence the expression of BIS1 in leaves of the C. roseus cultivar Little Bright Eyes. Unfortunately, despite several attempts, only a minor effect on the BIS1 transcript silencing and secologanin accumulation was obtained (SI Appendix, Fig. S4) . No difference in downstream MIA products, such as strictosidine or vindoline, was observed. Second, we transformed C. roseus hairy roots with BIS1-targeting RNAi-silencing constructs. Two stably transformed root lines with significantly reduced BIS1 mRNA levels were obtained (SI Appendix, Fig. S4C ). In these lines, MIAs accumulated at significantly decreased levels (SI Appendix, Fig. S4D ). Together these results support a role for BIS1 in the regulation of the iridoid pathway in planta.
BIS1 Expression Is Enriched in IPAP-Containing Tissues. The fragments per kilobase of exon per million fragments mapped (FPKM) values of BIS1 are too low to enable in situ hybridization signal detection (2) . Therefore, to assess the cell specificity of BIS1 expression, we generated two sets of C. roseus tissues for quantitative PCR (qPCR) analysis. The first set was derived from MVK  PMK  ORCA3  MYC2  SQS  STR2  MVD  AAS  DXS1  T16H2  HMGR1  SQE1  AO  NMT  HMGS  T16H1  AACT1  T19H  D4H  DAT  LAMT  PRX1  TDC  T16OMT  SLS1  MAT  SGD  SLS2  HMGR2  STR1  DXS2A  DXR  DXS2B  IO  8HGO  IS  BIS1  7DLH  HDR  G8O  CMK  HDS  GPPS-SSU  7DLGT  MECS Table S2 . Blue and yellow denote relative down-regulation and up-regulation, respectively.
leaves, from which we dissected the central vein as well as nearly veinless tissue, whereas the second set was derived from stems, from which we separated the epidermis from the rest of the stem tissue. qPCR analysis evidenced that the GES and G8O transcripts were enriched in the leaf central vein and peeled stem and absent from the stem epidermis (SI Appendix, Fig. S5 ), which is in agreement with their reported internal phloem-associated parenchyma (IPAP) localization (7, 30, 31) . Conversely, SGD transcripts were enriched in the stem epidermis and veinless leaf and markedly less abundant in peeled stem and the leaf central vein (SI Appendix, Fig. S5 ), which is in agreement with its reported epidermal localization (32) . BIS1 expression was enriched in the leaf central vein and peeled stem and largely absent from the stem epidermis (SI Appendix, Fig.  S5 ), hence correlating with the expression of the IPAP-specific iridoid pathway genes. Furthermore, BIS1 expression was clearly distinct from that of the ORCA3 gene, which was also strongly expressed in the stem epidermis (SI Appendix, Fig. S5 ), thus further supporting its specificity.
Discussion
Identification of a bHLH-Type Transcriptional Regulator of MIA Production. MIA production in the medicinal plant C. roseus requires tryptophan and IPP precursors that are shared with the primary metabolism as well as numerous other specialized metabolite pathways, such as of triterpenoids and sesquiterpenoids (5, 33) . Therefore, biosynthesis of (seco)-iridoids and MIAs requires a tight transcriptional coordination of genes. Our understanding of this regulatory circuit remains limited to date, because, in general, only a few transcriptional regulators of the MEP (or MVA) as well as of the downstream terpenoid pathways have been identified (1, 34) . Furthermore, MIA production in C. roseus involves a complex spatial organization, distributed in at least four cell types, and a marked and concerted elicitation of the pathway genes by JA treatment (2, 3) . This complexity undoubtedly requires an array of TFs (1), many of which remain to be discovered. The expression of several of these TFs may be JA inducible as part of the JA signaling cascade, as previously shown for ORCA3 and MYC2 (13, 15) . This feature has turned out to be a powerful tool in the past to find pathway-regulating TFs in different plant species (1, 4, 35) and has been also successfully exploited here to identify the TF BIS1 as a regulator of the iridoid pathway. BIS1 belongs to clade IVa of the bHLH family (27) , which is fundamentally different from the much larger MYC2-type TFs, because its members do not contain a known JAZ-interacting domain and thus seemingly lack a direct molecular connection to the currently known primary JA signaling module (1, 36) . Therefore, determination of the exact hierarchical position of BIS1 in the JA signaling cascade will need further study. BIS1 specifically transactivates the promoters of iridoid genes up to 7DLH and induces their expression in transformed hairy root and cell suspension cultures. In addition, the MEP genes are also up-regulated in BIS1-overexpressing cultures, resulting in a coordinated activation of the iridoid and its precursor pathways. Such coordination of the expression of MEP precursor and terpenoid pathway genes has been reported previously and ensures the coupling of primary with secondary metabolism at the appropriate time and place (37) and is in agreement with the spatial coexpression of the MEP and iridoid genes in the IPAP cells (31) .
To date, only one plant bHLH TF, phytochrome-interacting factor 5 (PIF5) from Arabidopsis, has been linked with the transcriptional activation of MEP pathway genes (38) . Conversely, only one member of the bHLH clade IVa, NAI1 from Arabidopsis, has been characterized to some extent and has been reported to be involved in the formation of ER bodies, ER-derived organelles that have only been described in the plant order of Brassicales, where they are ubiquitous in roots and seedlings (39) . However, NAI1 has not been linked with activation of MEP, terpenoid, or any (specialized) metabolite biosynthesis pathway yet. Because of the limited knowledge on TFs belonging to clade IVa and/or regulating MEP-dependent terpenoid biosynthesis (34) , it is too early to speculate on the evolutionary specificity of BIS1.
The regulatory circuit of BIS1 differs markedly from that controlling the biosynthesis of the indole moiety and subsequent MIA pathway branches that are under control of ORCA3, which in turn is controlled by MYC2 (13, 14) . Overall, the distinct BIS1 and ORCA3 circuits correlate well with the reported cell typespecific delineation of the pathway, with BIS1 targeting IPAPspecific genes. A 533-bp promoter sequence of the G8O gene had been isolated and shown to be sufficient for responsiveness to JA in C. roseus hairy roots (16) . This promoter fragment contains several putative TF-binding sites that differ from those of the ORCA3-dependent gene promoters and was therefore postulated to be regulated by a different transcriptional cascade, as corroborated by our study. How and whether the different circuits interact remains to be resolved. BIS1, MYC2, ORCA3, and probably other, yet unknown, MIA-regulating TFs are coinduced by JA elicitation, possibly a prerequisite to guarantee optimal pathway functioning. Indeed, ORCA3-regulated genes are not up-regulated by BIS1, and some of them are even downregulated. Conversely, in ORCA3-overexpressing cell cultures, BIS1 and several iridoid genes are down-regulated (Fig. 1C) (7) . Likewise, the effect of ORCA3 overexpression on, for instance, SGD expression in cell suspension cultures (up) was found to be opposite to that in hairy root cultures (down) (23) . The integration of the different circuits will need to be taken into account when engineering the production of MIA compounds in C. roseus cells.
BIS1 Boosts MIA Production Without Precursor Feeding. Due to the low in planta abundance of the valuable MIAs and their precursors, several metabolic engineering and synthetic biology programs were launched with the aim to create sustainable MIA resources. In this regard, the recent reconstitutions of the pathway up to strictosidine in both tobacco (7) and yeast (40) represent important milestones. However, the use of transcriptional regulators to activate multiple steps is considered most promising to engineer MIA synthesis in the endogenous plant source. This belief has been fostered by the discovery of ORCA3 (14) , the overexpression of which, however, was not sufficient to boost MIA production in C. roseus cultures.
In contrast to ORCA3, BIS1 overexpression boosted MIA production in C. roseus suspension cell cultures in the absence of exogenous precursors or JA elicitation. Although BIS1 "only" activated the pathway branch leading to loganic acid, its overexpression resulted in a dramatic increase, not only of loganic acid but also of downstream (seco)-iridoid and MIA products, such as secologanin, strictosidine, ajmalicine, serpentine, and tabersonine.
The biosynthetic route from strictosidine to tabersonine is largely unknown, but the seven-step biosynthesis pathway from tabersonine to vindoline has recently been fully elucidated and reassembled in yeast (41) . Until now, production of vindoline in C. roseus suspension cultures seemed problematic, based on its complex cell-specific regulation. However, considering that the tabersonine-to-vindoline pathway can be assembled in a single yeast cell (41) and that the BIS1-overexpressing cells constitutively accumulate tabersonine, the latter cells may serve as a promising C. roseus-based platform for further metabolic engineering toward sustainable production of vindoline and, ultimately, vinblastine and vincristine. Successful engineering may depend not only on the full elucidation and reconstitution of the pathway at the enzyme level but also on the identification of additional regulatory TFs of the MIA or its precursor pathways.
